43 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
otherwise expressly stated or the context otherwise requires. Table of Contents 4
PART I Item 1. BUSINESS Overview and Mission We are a leading … management of a key set of initiatives to fulfill our mission and drive long-term growth and profitability. Testing Our tests are generally designed
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
27 Feb 24
Results of Operations and Financial Condition
4:05pm
to achieve our Mission and Vision to reach more patients with life-saving precision medicine. As we look beyond 2024, we are excited about the new … to continue to invest in the research and development and technology innovations to achieve its Mission and Vision to reach more patients with life-saving
8-K
MYGN
Myriad Genetics, Inc.
27 Feb 24
Results of Operations and Financial Condition
4:05pm
in the research and development and technology innovations to achieve its Mission and Vision to reach more patients with life-saving precision medicine
8-K
EX-99.1
si2adf
16 Jan 24
Results of Operations and Financial Condition
9:00am
424B5
b6yi0lv
13 Nov 23
Prospectus supplement for primary offering
6:02am
424B5
o7vla4va5p64j0irsl7
8 Nov 23
Prospectus supplement for primary offering
4:05pm
ARS
gxabc 6ed6m6t
12 Apr 23
Annual report to shareholders
4:10pm
8-K
EX-99.1
hpev lhs9zegdiux9me
24 Feb 22
Provides Updates on Product Performance and Growth Initiatives
9:03am